Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
AKLPF On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 06/27/14 All times are local (Market data is delayed by at least 15 minutes).

akela pharma inc (AKLPF) Snapshot

Open
$0.0001
Previous Close
$0.0001
Day High
$0.0001
Day Low
$0.0001
52 Week High
10/17/13 - $0.0001
52 Week Low
10/17/13 - $0.0001
Market Cap
--
Average Volume 10 Days
60.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AKELA PHARMA INC (AKLPF)

Related News

No related news articles were found.

akela pharma inc (AKLPF) Related Businessweek News

No Related Businessweek News Found

akela pharma inc (AKLPF) Details

Akela Pharma, Inc. operates as a specialty contract pharmaceutical formulation developer in the United States. It offers contract pharma services comprising formulation and process development of drug in tablets, capsules, multiparticulates, fast formulations, oral and topical liquids, powders for suspension/reconstitution, and semi-solid forms. The company also provides analytical services, which include research and development analytical testing and support for formulation development; analytical method development and phase-appropriate validation; quality control testing for API and raw materials release; and stability testing and ICH compliant stability storage. In addition, it offers drug delivery solutions, such as hot melt extrusion for amorphous dispersions, spray-drying for amorphous dispersions, controlled release dosage forms, liquid solutions (encapsulated and bottled), and novel dosage forms, as well as beads, granulation, and drug layering services. Further, the company’s contract services consist of handling of potent compounds; pharmaceutical patent litigation support services; GMP clinical and commercial manufacturing; clinical labeling and packaging; and IP validation and contestation consulting services. The company was formerly known as LAB International Inc. and changed its name to Akela Pharma, Inc. in June 2007. Akela Pharma, Inc. was founded in 1979 and is headquartered in Austin, Texas.

57 Employees
Last Reported Date: 03/30/12
Founded in 1979

akela pharma inc (AKLPF) Top Compensated Officers

Principal Financial Officer
Total Annual Compensation: --
President of LAB Pre-Clinical Research Inc
Total Annual Compensation: --
Executive Vice President and Corporate Secret...
Total Annual Compensation: --
Chief Scientific Officer of LAB Pharma
Total Annual Compensation: --
Chief Operating Officer of Pre Clinical
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

akela pharma inc (AKLPF) Key Developments

Rudy Emmelot Resigns from Akela Pharma Inc

Rudy Emmelot has announced his resignation as President, CEO and Member of the Board of Directors of Akela Pharma Inc.

Akela Pharma Applies For voluntary Delisting From TSX

Akela Pharma Inc. has applied for voluntary delisting of its securities from the Toronto Stock Exchange (TSX). Subject to confirmation from the TSX, it is expected that securities in Akela Pharma will be delisted from TSX at the close of market on Dec. 7, 2012. The decision to delist has been made due to Akela Pharma's inability to maintain the continuous listing requirements of the TSX. The securities will not be actively listed on a market.

Akela Pharma Inc. Announces Resignation of Beng Lai as Board of Director

Akela Pharma Inc. announced that Mr. Beng Lai is stepping down as a member of the Board of Directors of the company in order that he can devote more time to his principal business role as the President of a registered securities dealer. Mr. Lai joined the Board of Akela in December of 2010.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKLPF:US $0.00 USD 0.00

AKLPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AKLPF.
View Industry Companies
 

Industry Analysis

AKLPF

Industry Average

Valuation AKLPF Industry Range
Price/Earnings 0.0x
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow 0.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AKELA PHARMA INC, please visit www.akelapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.